Therefore, breast cancer cells expressing RUNX2 and CBFβ can exploit the various growth factors involved in the homeostasis of bone formation to allow tumor cell mediated osteoclastogenesis and growth of metastatic cells in this environment. Here, RUNX2 is linked to breast carcinoma.